US FDA Works To Stay Ahead Of Benzodiazepine Misuse

FDA and NIH are looking to spark research on approaches to reduce use of benzodiazepines and to help mitigate issues with withdrawal associated with the widely prescribed therapies.

NIH and FDA are keeping their eye out for products that could help patients withdraw from benzodiazepines. • Source: Alamy

Concerns about overprescribing and misuse of benzodiazepines are nothing new for the US Food & Drug Administration. Questions about potential abuse of the drugs date back to the 1980s.

However, in the context of the more recent prescription opioid abuse crisis, there is increased interest both in avoiding the...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Drug Safety

More from Pink Sheet